Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.855
-0.025 (-2.81%)
Mar 9, 2026, 2:07 PM EDT - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $7.33 million as of March 9, 2026. Its market cap has decreased by -32.09% in one year.
Market Cap
7.33M
Enterprise Value
464.15K
1-Year Change
-32.09%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.33M, a decrease of -73.90%. That is a compound annual growth rate of -14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.20M | 60.00% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 7.34M |
| Kiora Pharmaceuticals | 7.30M |
| Evogene | 7.27M |
| Addex Therapeutics | 6.85M |
| XTL Biopharmaceuticals | 6.73M |
| Moolec Science | 6.73M |
| Mustang Bio | 6.64M |
| Creative Medical Technology Holdings | 6.52M |